- Home
- GURE vs SNGX Comparison
GURE vs SNGX Comparison
Compare GURE & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- SNGX
- Stock Information
- Founded
- GURE 2006
- SNGX 1987
- Country
- GURE China
- SNGX United States
- Employees
- GURE N/A
- SNGX N/A
- Industry
- GURE Major Chemicals
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- SNGX Health Care
- Exchange
- GURE Nasdaq
- SNGX Nasdaq
- Market Cap
- GURE 6.5M
- SNGX 7.4M
- IPO Year
- GURE 1992
- SNGX 1987
- Fundamental
- Price
- GURE $0.57
- SNGX $2.89
- Analyst Decision
- GURE
- SNGX
- Analyst Count
- GURE 0
- SNGX 0
- Target Price
- GURE N/A
- SNGX N/A
- AVG Volume (30 Days)
- GURE 27.7K
- SNGX 50.1K
- Earning Date
- GURE 01-07-2025
- SNGX 11-08-2024
- Dividend Yield
- GURE N/A
- SNGX N/A
- EPS Growth
- GURE N/A
- SNGX N/A
- EPS
- GURE N/A
- SNGX N/A
- Revenue
- GURE $12,802,982.00
- SNGX $364,183.00
- Revenue This Year
- GURE N/A
- SNGX N/A
- Revenue Next Year
- GURE N/A
- SNGX $76.64
- P/E Ratio
- GURE N/A
- SNGX N/A
- Revenue Growth
- GURE N/A
- SNGX N/A
- 52 Week Low
- GURE $0.51
- SNGX $1.83
- 52 Week High
- GURE $1.79
- SNGX $19.20
- Technical
- Relative Strength Index (RSI)
- GURE 42.84
- SNGX 34.89
- Support Level
- GURE $0.59
- SNGX $2.93
- Resistance Level
- GURE $0.64
- SNGX $3.32
- Average True Range (ATR)
- GURE 0.06
- SNGX 0.20
- MACD
- GURE 0.00
- SNGX -0.03
- Stochastic Oscillator
- GURE 37.58
- SNGX 15.38
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).